Daniil Gataulin
Stock Analyst at Chardan Capital
(4.89)
# 64
Out of 5,033 analysts
117
Total ratings
65.71%
Success rate
63.55%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniil Gataulin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRD Opus Genetics | Initiates: Buy | $9 | $1.98 | +354.55% | 1 | Oct 16, 2025 | |
| OCS Oculis Holding AG | Maintains: Buy | $33 → $51 | $21.82 | +133.73% | 8 | Oct 8, 2025 | |
| KOD Kodiak Sciences | Maintains: Neutral | $14 | $17.70 | -20.90% | 3 | Oct 6, 2025 | |
| OCUL Ocular Therapeutix | Maintains: Buy | $21 | $12.18 | +72.41% | 2 | Oct 2, 2025 | |
| ZURA Zura Bio | Maintains: Buy | $10 | $3.37 | +196.74% | 2 | Sep 30, 2025 | |
| QURE uniQure | Maintains: Buy | $35 → $76 | $63.92 | +18.90% | 8 | Sep 25, 2025 | |
| OCGN Ocugen | Maintains: Buy | $7 | $1.62 | +332.10% | 14 | Sep 19, 2025 | |
| TRML Tourmaline Bio | Downgrades: Neutral | $70 → $48 | $47.93 | +0.15% | 4 | Sep 10, 2025 | |
| RGNX REGENXBIO | Maintains: Buy | $52 | $12.64 | +311.39% | 13 | Sep 8, 2025 | |
| OTLK Outlook Therapeutics | Maintains: Neutral | $3 | $1.48 | +102.70% | 10 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $61 | $12.19 | +400.41% | 6 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 | $8.24 | +324.76% | 5 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 | $4.46 | +639.91% | 8 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 | $7.51 | +99.73% | 7 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 | $1.83 | +118.58% | 8 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 | $12.03 | +124.44% | 12 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.09 | - | 5 | Jul 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $220 | $0.58 | +37,978.75% | 1 | Mar 7, 2024 |
Opus Genetics
Oct 16, 2025
Initiates: Buy
Price Target: $9
Current: $1.98
Upside: +354.55%
Oculis Holding AG
Oct 8, 2025
Maintains: Buy
Price Target: $33 → $51
Current: $21.82
Upside: +133.73%
Kodiak Sciences
Oct 6, 2025
Maintains: Neutral
Price Target: $14
Current: $17.70
Upside: -20.90%
Ocular Therapeutix
Oct 2, 2025
Maintains: Buy
Price Target: $21
Current: $12.18
Upside: +72.41%
Zura Bio
Sep 30, 2025
Maintains: Buy
Price Target: $10
Current: $3.37
Upside: +196.74%
uniQure
Sep 25, 2025
Maintains: Buy
Price Target: $35 → $76
Current: $63.92
Upside: +18.90%
Ocugen
Sep 19, 2025
Maintains: Buy
Price Target: $7
Current: $1.62
Upside: +332.10%
Tourmaline Bio
Sep 10, 2025
Downgrades: Neutral
Price Target: $70 → $48
Current: $47.93
Upside: +0.15%
REGENXBIO
Sep 8, 2025
Maintains: Buy
Price Target: $52
Current: $12.64
Upside: +311.39%
Outlook Therapeutics
Aug 28, 2025
Maintains: Neutral
Price Target: $3
Current: $1.48
Upside: +102.70%
Aug 15, 2025
Maintains: Buy
Price Target: $61
Current: $12.19
Upside: +400.41%
Aug 15, 2025
Maintains: Buy
Price Target: $35
Current: $8.24
Upside: +324.76%
Aug 13, 2025
Maintains: Buy
Price Target: $33
Current: $4.46
Upside: +639.91%
Aug 11, 2025
Maintains: Buy
Price Target: $15
Current: $7.51
Upside: +99.73%
Aug 8, 2025
Maintains: Buy
Price Target: $4
Current: $1.83
Upside: +118.58%
Aug 7, 2025
Maintains: Buy
Price Target: $27
Current: $12.03
Upside: +124.44%
Jul 18, 2025
Downgrades: Neutral
Price Target: n/a
Current: $4.09
Upside: -
Mar 7, 2024
Maintains: Buy
Price Target: $220
Current: $0.58
Upside: +37,978.75%